Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction — Shingo Matsumoto (2024) | RDL Network
Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction
Article 2024 en
Authors
SM
Shingo Matsumoto
AH
Alasdair Henderson
LS
Li Shen
Abstract
1 min read
In this observational analysis of non-randomized BB treatment, there was no suggestion that BB use was associated with worse HF outcomes in HFmrEF/HFpEF, even after extensive adjustment for other prognostic variables.
Mauro Gori, Marco Marini, Lucio Gonzini, Samuela Carigi, Luisa De Gennaro, Piero Gentile, Giuseppe Leonardi, Francesco Orso, Davide Tinti, Donata Lucci, Massimo Iacoviello, Alessandro Navazio, Enrico Ammirati, Annamaria Municinò, Manuela Benvenuto, Leonarda Cassaniti, Luigi Tavazzi, Aldo Maggioni, Renata De Maria
Vijeta Bhambhani, Jorge R. Kizer, João A.C. Lima, Pim van der Harst, Hossein Bahrami, Matthew Nayor, Christopher R. de Filippi, Danielle Enserro, Michael J. Blaha, Mary Cushman, Thomas J. Wang, Ron T. Gansevoort, Caroline S. Fox, Hanna K. Gaggin, Willem J. Kop, Kiang Liu, Ramachandran S. Vasan, Bruce M. Psaty, Douglas S. Lee, Frank P. Brouwers, Hans L. Hillege, Traci M. Bartz, Emelia Benjamin, Cheeling Chan,
Leanne Mooney, Pardeep S. Jhund, Inder S. Anand, Akshay S. Desai, Aldo Maggioni, Jean L. Rouleau, Karl Swedberg, Dirk J. van Veldhuisen, Michael R. Zile, Scott D. Solomon, John J.V. McMurray
Discussion(0)
No comments yet. Be the first to comment.